Aug 11 (Reuters) - Hospira Inc:
* Launches generic oxaliplatin injection
* Says medication is a generic version of Sanofi-Aventis' Eloxatin
* Says FDA approved oxaliplatin injection in the United States
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Launches generic oxaliplatin injection
* Says medication is a generic version of Sanofi-Aventis' Eloxatin
* Says FDA approved oxaliplatin injection in the United States
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2009 AFX News
